Verastem (VSTM) Cash & Equivalents (2011 - 2026)
Verastem (VSTM) recorded Cash & Equivalents of $136.35 million in Q2 2026, down 17.0% from $164.32 million a year earlier and down 17.6% from the prior quarter.
Powered by 
Analysis
Verastem (VSTM) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Verastem reported Cash & Equivalents of $204.99 million, up 130.8% from FY2024.
- Annual Cash & Equivalents has increased for four straight years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $88.82 million in FY2024 (+14.0%), $77.91 million in FY2023 (+4.0%), $74.93 million in FY2022 (+252.6%) and $21.25 million in FY2021 (-68.6%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in seven of the last eight quarters, with growth averaging 43.9%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 252.6% in Q4 2022, against a decline of 85.7% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $165.55 million (Q1 2026), $204.99 million (Q4 2025) and $137.71 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Verastem | 714.81 Mn | 71.44 Mn | 36.32 Mn | 136.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.35 Mn |
| Mar 31, 2026 | 165.55 Mn |
| Dec 31, 2025 | 204.99 Mn |
| Sep 30, 2025 | 137.71 Mn |
| Jun 30, 2025 | 164.32 Mn |
| Mar 31, 2025 | 117.57 Mn |
| Dec 31, 2024 | 88.82 Mn |
| Sep 30, 2024 | 113.18 Mn |
| Jun 30, 2024 | 83.37 Mn |
| Mar 31, 2024 | 81.32 Mn |
| Dec 31, 2023 | 77.91 Mn |
| Sep 30, 2023 | 94.99 Mn |
| Jun 30, 2023 | 183.09 Mn |
| Mar 31, 2023 | 97.26 Mn |
| Dec 31, 2022 | 74.93 Mn |
| Sep 30, 2022 | 78.17 Mn |
| Jun 30, 2022 | 63.95 Mn |
| Mar 31, 2022 | 46.69 Mn |
| Dec 31, 2021 | 21.25 Mn |
| Sep 30, 2021 | 24.31 Mn |
API Access
Verastem Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();